---
title: "Intuitive Surgical Inc Q2 2026: Revenue $2.89B, EPS $2.29— 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293389376.md"
description: "Intuitive Surgical Inc reported Q2 2026 revenue of $2.89B, up 18.6% YoY, with net income of $818.1M and diluted EPS of $2.29. Growth was driven by an 18% increase in systems placements (468 units), rising procedure volumes for da Vinci and Ion systems, and strong recurring revenue. The company also noted operational progress with da Vinci 5 placements and regulatory clearances, while managing tariff-related cost volatility."
datetime: "2026-07-21T21:31:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293389376.md)
  - [en](https://longbridge.com/en/news/293389376.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293389376.md)
generator: "portal-rs"
---

# Intuitive Surgical Inc Q2 2026: Revenue $2.89B, EPS $2.29— 10-Q Summary

Intuitive Surgical Inc reported second-quarter 2026 results with revenue of $2.89B, net income of $818.1M and diluted EPS of $2.29, each rising sharply versus the year‑ago quarter as systems placements, recurring revenue and procedure volumes strengthened.

**Financial Highlights**

-   Revenue was $2.89B, compared with $2.44B in the prior-year quarter; YoY change 18.6%.
-   Net income was $818.1M, compared with $658.4M in the prior-year quarter; YoY change 24.3%.
-   Diluted EPS was $2.29, compared with $1.81 in the prior-year quarter; YoY change 26.5%.

**Business Highlights**

-   Total revenue rose 19% year over year to $2.89B in Q2, with recurring revenue representing roughly 85% of the mix, driven by instruments, service and operating leases.
-   Systems placements increased 18% with 468 units placed; operating-lease placements accounted for about 54% of placements, lifting variable lease revenue.
-   Procedure momentum continued: approximately 889K da Vinci procedures (up 15%) and about 47.9K Ion procedures (up 36%). Installed bases reached ~11,710 da Vinci systems and ~1,096 Ion systems.
-   Operational progress included 246 da Vinci 5 placements in the quarter, expanded adoption of da Vinci 5/SP instruments, and multiple global regulatory clearances.
-   Tariff volatility influenced costs during the period; the company received IEEPA tariff refunds, managed supply-chain risks and increased inventory to bolster resilience.

Original SEC Filing: INTUITIVE SURGICAL INC \[ ISRG \] - 10-Q - Jul. 21, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md)
- [ISUL.US](https://longbridge.com/en/quote/ISUL.US.md)

## Related News & Research

- [Is Intuitive Surgical's post-earnings selloff a buying opportunity?](https://longbridge.com/en/news/294098998.md)
- [Intuitive Surgical outlines AI roadmap toward supervised autonomy for da Vinci systems](https://longbridge.com/en/news/293622678.md)
- [Oliver Jaster lifts MAX Automation voting stake to 66.71% from 65.98%](https://longbridge.com/en/news/297955838.md)
- [Franklin Templeton announces dividend of R$ 1.15 per unit for BRF1RABDR 002 ISIN](https://longbridge.com/en/news/297822458.md)
- [Alexandria Real Estate Equities declares Q3 2026 dividend of R$ 0.63 per unit](https://longbridge.com/en/news/297928934.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**